Summary
The disposition of methadone was studied in eight opiate dependent subjects during detoxification. Plasma concentrations were determined by mass fragmentography for 48 hours after administration of methadone 20 mg as tablets and simultaneous intravenous injection of deuterium-labelled methadone 20 mg. Pharmacokinetic parameters were calculated for the intravenous dose assuming a two compartment open model. Bioavailability was determined by comparing the areas under the plasma concentration versus time curves of unlabelled and labelled methadone. The beta-phase plasma half-lives varied five-fold, with a range from 8.5 to 47 h. The apparent volumes of distribution varied from 2.1 to 5.61/kg. Five patients had a bioavailability exceeding 90%, and three had lower bioavailabilities of between 41 and 76%. The unlabelled and labelled drug appeared to be pharmacokinetically equivalent. The data show that for a majority of these subjects the bioavailability was higher than 45%, the previously reported value. The marked individual variation in methadone pharmacodynamics and kinetics, and the possibilities both of cellular and methabolic tolerance, require an individually optimized dosage regimen.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Beaver WT, Wallenstein SI, Houde RW, Rogers A (1967) A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin Pharmacol Ther 8: 415–426
Sullivan HR, Marshall FJ, McMahon RE, Änggård E, Holmstrand J, Gunne L-M (1975) Mass fragmentographic determination of unlabeled and deuterium labeled methadone in human plasma. Possibilities for measurements of steady-state pharmacokinetics. Biomed Mass Spectrom 2: 197–200
Metzler CM, Elfring GL, McEwen AJ (1974) A users manual for NONLIN and associated programs. Upjohn Co, Kalamazoo, MI
Gibaldi M, Perrier D (1975) Pharmacokinetics. Marcel Dekker, New York
Documenta Geigy Scientific Tables (1970) Ciba-Geigy, Basle, S 555
Änggård E, Nilsson M-I, Holmstrand J, Gunne L-M (1979) Pharmacokinetics of methadone during maintenance therapy: Pulse labeling with deuterated methadone in the steady state. Eur J Clin Pharmacol 16: 53–57
Inturrisi CE, Verebely K (1972) The levels of methadone in the plasma in methadone maintenance. Clin Pharmacol Ther 13: 633–637
Olsen GD, Wendel HA, Livermore JD, Leger RM, Lynn RK, Gerber N (1977) Clinical effects and pharmacokinetics of racemic methadone and its optic isomers. Clin Pharmacol Ther 21: 147–157
Strong JM, Dutcher JS, Lee W-K, Atkinson Jr AJ (1975) Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method. Clin Pharmacol Ther 18: 613–622
Änggård E, Gunne L-M, Holmstrand J, McMahon RE, Sandberg C-G, Sullivan HR (1975) Disposition of methadone in methadone maintenance. Clin Pharmacol Ther 17: 258–266
Verebely K, Volavka J, Mulé S, Resnick R (1975) Methadone in man: Pharmacokinetics and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 18: 180–190
Nilsson M-I, Widerlöv E, Meresaar U, Änggård E (1981) The effect of urinary pH on the disposition of methadone in man. Submitted to Eur J Clin Pharmacol
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meresaar, U., Nilsson, M.I., Holmstrand, J. et al. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol 20, 473–478 (1981). https://doi.org/10.1007/BF00542102
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542102